Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns BioPharma Dive
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns BioPharma Dive
Ядерная медицина в Кирове: новые возможности в борьбе с раком и сердечными патологиями navigator-kirov.ru
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study srnnews.com
Ядерная медицина в Кирове: новые возможности в борьбе с раком и сердечными патологиями navigator-kirov.ru
"Просто космос": онколог рассказал о прорывах в лечении рака груди РИА Томск
Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer Business Wire
First all-island residential training programme for cancer patient advocates University College Dublin
Transition Toward Multimodal Integration in Cancer Therapy: Biological Rationales, Clinical Efficacy, and Pharmacological Challenges Cureus
Clinical Trial Access Must Keep Pace with Cancer Care Onco'Zine
Early-onset bowel cancer shows distinct biological and clinical features news-medical.net
How A $96M Gift Is Transforming Pediatric Brain Cancer Clinical Trial Infrastructure Clinical Leader
От родинки до диагноза: как в Казани выявляют рак кожи на ранней стадии Вечерняя Казань
KSMO 2026 to draw 2,300 cancer experts to Seoul, push Asia-led precision oncology Korea Biomedical Review
She sold fruits to fund her education, then became a cancer-care pioneer: The remarkable journey of Dr Vi The Times of India
В Башкирии вырос уровень выявляемости рака на ранней стадии UfacityNews.ru